These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 30214464)

  • 21. Current and Emerging Reconstituted HDL-apoA-I and HDL-apoE Approaches to Treat Atherosclerosis.
    Valanti EK; Dalakoura-Karagkouni K; Sanoudou D
    J Pers Med; 2018 Oct; 8(4):. PubMed ID: 30282955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cholesteryl Ester Transfer Protein Inhibition With Anacetrapib Decreases Fractional Clearance Rates of High-Density Lipoprotein Apolipoprotein A-I and Plasma Cholesteryl Ester Transfer Protein.
    Reyes-Soffer G; Millar JS; Ngai C; Jumes P; Coromilas E; Asztalos B; Johnson-Levonas AO; Wagner JA; Donovan DS; Karmally W; Ramakrishnan R; Holleran S; Thomas T; Dunbar RL; deGoma EM; Rafeek H; Baer AL; Liu Y; Lassman ME; Gutstein DE; Rader DJ; Ginsberg HN
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):994-1002. PubMed ID: 26966279
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-density lipoprotein and atherosclerosis: Roles of lipid transporters.
    Uehara Y; Saku K
    World J Cardiol; 2014 Oct; 6(10):1049-59. PubMed ID: 25349649
    [TBL] [Abstract][Full Text] [Related]  

  • 24. High-Density Lipoprotein, Lecithin: Cholesterol Acyltransferase, and Atherosclerosis.
    Ossoli A; Pavanello C; Calabresi L
    Endocrinol Metab (Seoul); 2016 Jun; 31(2):223-9. PubMed ID: 27302716
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Hyperhomocysteinemia and high-density lipoprotein metabolism in cardiovascular disease.
    Liao D; Yang X; Wang H
    Clin Chem Lab Med; 2007; 45(12):1652-9. PubMed ID: 18020970
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A selective peroxisome proliferator-activated receptor δ agonist PYPEP suppresses atherosclerosis in association with improvement of the serum lipoprotein profiles in human apolipoprotein B100 and cholesteryl ester transfer protein double transgenic mice.
    Naya N; Fukao K; Nakamura A; Hamada T; Sugimoto M; Kojima M; Yoshimura N; Uwabe K; Imagawa K; Nomura K; Hara S; Nakano T; Iwasaki T; Shinosaki T; Hanasaki K
    Metabolism; 2016 Jan; 65(1):16-25. PubMed ID: 26683793
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Very low density lipoprotein metabolism and plasma adiponectin as predictors of high-density lipoprotein apolipoprotein A-I kinetics in obese and nonobese men.
    Chan DC; Barrett PH; Ooi EM; Ji J; Chan DT; Watts GF
    J Clin Endocrinol Metab; 2009 Mar; 94(3):989-97. PubMed ID: 19116237
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Lipid metabolism abnormalities in Chronic Kidney Disease].
    Bianchi S; Baronti A; Cominotto R; Bigazzi R
    G Ital Nefrol; 2016 Malattie Metaboliche e Rene; 33(S68):. PubMed ID: 27960010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Natural human apoA-I mutations L141RPisa and L159RFIN alter HDL structure and functionality and promote atherosclerosis development in mice.
    Tiniakou I; Kanaki Z; Georgopoulos S; Chroni A; Van Eck M; Fotakis P; Zannis VI; Kardassis D
    Atherosclerosis; 2015 Nov; 243(1):77-85. PubMed ID: 26363436
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low high-density lipoprotein cholesterol: physiological background, clinical importance and drug treatment.
    Hersberger M; von Eckardstein A
    Drugs; 2003; 63(18):1907-45. PubMed ID: 12930163
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-Density Lipoprotein Processing and Premature Cardiovascular Disease.
    Rosales C; Gillard BK; Gotto AM; Pownall HJ
    Methodist Debakey Cardiovasc J; 2015; 11(3):181-5. PubMed ID: 26634027
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structural determinants in ApoA-I amyloidogenic variants explain improved cholesterol metabolism despite low HDL levels.
    Del Giudice R; Domingo-Espín J; Iacobucci I; Nilsson O; Monti M; Monti DM; Lagerstedt JO
    Biochim Biophys Acta Mol Basis Dis; 2017 Dec; 1863(12):3038-3048. PubMed ID: 28887204
    [TBL] [Abstract][Full Text] [Related]  

  • 33. High density lipoproteins: Measurement techniques and potential biomarkers of cardiovascular risk.
    Hafiane A; Genest J
    BBA Clin; 2015 Jun; 3():175-88. PubMed ID: 26674734
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High-Density Lipoprotein Mimetics: a Therapeutic Tool for Atherosclerotic Diseases.
    Ikenaga M; Higaki Y; Saku K; Uehara Y
    J Atheroscler Thromb; 2016; 23(4):385-94. PubMed ID: 26830201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Residual dyslipidemia according to low-density lipoprotein cholesterol, non-high-density lipoprotein cholesterol, and apolipoprotein B among statin-treated US adults: National Health and Nutrition Examination Survey 2009-2010.
    Wong ND; Chuang J; Zhao Y; Rosenblit PD
    J Clin Lipidol; 2015; 9(4):525-32. PubMed ID: 26228670
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Role of HDL in Cholesterol Efflux and Reverse Cholesterol Transport].
    Ayaori M
    Rinsho Byori; 2016 Jan; 64(1):57-65. PubMed ID: 27192798
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Is Isolated Low High-Density Lipoprotein Cholesterol a Cardiovascular Disease Risk Factor? New Insights From the Framingham Offspring Study.
    Bartlett J; Predazzi IM; Williams SM; Bush WS; Kim Y; Havas S; Toth PP; Fazio S; Miller M
    Circ Cardiovasc Qual Outcomes; 2016 May; 9(3):206-212. PubMed ID: 27166203
    [TBL] [Abstract][Full Text] [Related]  

  • 38. JCL roundtable: High-density lipoprotein function and reverse cholesterol transport.
    Cuchel M; Rohatgi A; Sacks FM; Guyton JR
    J Clin Lipidol; 2018; 12(5):1086-1094. PubMed ID: 30314802
    [TBL] [Abstract][Full Text] [Related]  

  • 39. High-density lipoprotein cholesterol efflux capacity and cardiovascular risk in autoimmune and non-autoimmune diseases.
    Hafiane A; Favari E; Daskalopoulou SS; Vuilleumier N; Frias MA
    Metabolism; 2020 Mar; 104():154141. PubMed ID: 31923386
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Impact of genetic deletion of platform apolipoproteins on the size distribution of the murine lipoproteome.
    Gordon SM; Li H; Zhu X; Tso P; Reardon CA; Shah AS; Lu LJ; Davidson WS
    J Proteomics; 2016 Sep; 146():184-94. PubMed ID: 27385375
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.